STACY ROYER: Open Payments
NPI 1053911149 · DRIPPING SPRINGS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,437 in 75 payments from 13 companies in 2025. Trend: 2023 $1,247 · 2024 $1,373 · 2025 $1,437
Food & beverage: $1,437
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $265 |
| AstraZeneca Pharmaceuticals LP | 8 | $209 |
| Novo Nordisk Inc | 11 | $192 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $182 |
| PFIZER INC. | 9 | $158 |
| Bausch Health US, LLC | 6 | $115 |
| Lilly USA, LLC | 5 | $80 |
| GlaxoSmithKline, LLC. | 4 | $69 |
| Medtronic, Inc. | 2 | $51 |
| Dexcom, Inc. | 2 | $47 |
Products named: JARDIANCE, AIRSUPRA, APLENZIN, UBRELVY, VRAYLAR, QULIPTA, Ozempic, NURTEC ODT.
Industry payments across TX — which companies pay providers there.
